Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Clinical trial NCT06180083 · COMPLETED

Trial details

NCT number: NCT06180083
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis Perennial Allergic Rhinitis

Start date: 2023-03-24
Primary completion: 2023-04-26
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.